Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT07820306
Starting soon Not applicable

Roy Adaptation Model-Based Prenatal Education in Hypertensive Pregnant Women

NCT07820306 · tracked via the Priya Life Science Turkey tracker
Sponsor
Istanbul University - Cerrahpasa
Phase
Not applicable
Started
2026-09-16
Last updated
2026-09-23

Condition(s) studied

Hypertensive Disorders of Pregnancy (HDP)

Investigational drug(s) / intervention(s)

Roy Adaptation Model-Based Prenatal Education

Roy Adaptation Model-Based Prenatal Education: Roy Adaptation Model-based prenatal education will be provided face-to-face by the researcher to pregnant women with hypertensive disorders of pregnancy. The education will be delivered in two sessions, one week apart, with each session lasting approximately 45 minutes. The educational content will address hypertensive disorders of pregnancy, blood pressure monitoring, healthy lifestyle behaviors during pregnancy, stress management, adaptation to physical and psychosocial changes during pregnancy, and seeking support from healthcare professionals. Participants will also receive a blood pressure monitoring chart for home monitoring. The intervention is specifically structured according to the four adaptive modes of the Roy Adaptation Model: physiological-physical, self-concept, role function, and interdependence.

Study summary

This study aims to evaluate the effect of Roy Adaptation Model-based prenatal education on perceived stress and quality of life in pregnant women with hypertensive disorders of pregnancy.

Pregnant women with hypertensive disorders who meet the eligibility criteria will be randomly assigned to either an intervention group or a control group. Participants in the intervention group will receive prenatal education based on the Roy Adaptation Model in two face-to-face sessions, one week apart. The control group will receive routine antenatal care. Blood pressure monitoring will be recommended for participants in both groups.

Perceived stress and quality of life will be assessed before the education and after the intervention. The study will investigate whether Roy Adaptation Model-based prenatal education helps reduce perceived stress and improve quality of life among pregnant women with hypertensive disorders.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * Pregnant women who apply to the antenatal outpatient clinic of the relevant hospital. * Women diagnosed by a physician with a hypertensive disorder of pregnancy. Women who are between 20 and 32 weeks of gestation. * Women aged 18 years or older. * Primiparous or multiparous pregnant women. * Women who can read and understand Turkish and communicate in Turkish. * Women who are willing to participate in the study. Exclusion Criteria: * Pregnant women with severe preeclampsia, eclampsia, HELLP syndrome, or a clinical condition requiring emergency obstetric intervention. * Pregnant women who are hospitalized or scheduled for hospitalization at the beginning of the study. * Pregnant women diagnosed with fetal anomaly or intrauterine fetal death. * Pregnant women with severe psychiatric, neurological, or cognitive impairment that may prevent participation in the education sessions or completion of the data collection instruments. * Pregnant women who develop a serious obstetric or clinical complication during the study that may affect the primary outcomes of the study.

Primary outcome measure(s)

  • Perceived Stress Level in High-Risk Pregnancies — At baseline (before the first education session) and 2 weeks after baseline
    Perceived stress level will be assessed using the High-Risk Pregnancy Perceived Stress Scale. Higher scores indicate higher perceived stress.

Trial sites (1)

FacilityCityRegionStatus
Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi Istanbul Turkey (Türkiye)

More Istanbul University - Cerrahpasa trials in Turkey

Postoperative Residual Neuromuscular Block and Passive Smoke Exposure in Pediatric Dental Patients Starting soon
Evaluation of Upper Extremity Functions in Obesity Hypoventilation Syndrome Patients Starting soon
Evaluation of the Effectiveness of the Pecha Kucha-Supported Microteaching Method in Nursing Process Education Active, not recruiting
Effect of Health Promotion Model-Based Oculomotor Exercise Program on Sleep Quality in Older Adults Starting soon
Validity and Reliability of the Exergame Enjoyment Questionnaire (EEQ) in Turkish Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07820306 on ClinicalTrials.gov ↗ ← All trials in Turkey